74150-27-9
C19H18N4O2
334.37
640-420-7
| Availability: | |
|---|---|
Product Description
Pimobendan (C₂₀H₁₈N₄O₄) is a selective phosphodiesterase III inhibitor and calcium sensitizer widely used in veterinary cardiology. It is commonly prescribed to treat congestive heart failure in dogs, improving cardiac output, reducing symptoms of heart failure, and enhancing quality of life.
Pimobendan is valued for its dual mechanism of action, combining positive inotropic effects with vasodilation, making it a cornerstone therapy for canine heart disease management.
Product Name: Pimobendan
Synonyms: Vetmedin, Pimobendan Hydrochloride (for hydrochloride salt)
Chemical Formula: C₂₀H₁₈N₄O₄
CAS Number: 20335-16-4
Molecular Weight: 386.39 g/mol
Appearance: White to off-white crystalline powder
Odor: Odorless
Solubility: Slightly soluble in water; soluble in organic solvents such as methanol and ethanol
| Property | Typical Value |
|---|---|
| Purity | ≥ 99% (pharmaceutical grade) |
| Melting Point | 184 – 188 °C |
| Density | 1.35 g/cm³ |
| Stability | Stable under recommended storage conditions; protect from light and moisture |
| Hygroscopicity | Non-hygroscopic |
| Form | Crystalline powder |
Pimobendan is synthesized via multi-step organic synthesis under GMP conditions. Quality control ensures:
High chemical and pharmaceutical purity
Low residual solvents and impurities
Compliance with veterinary pharmaceutical regulations
Each batch undergoes HPLC assay, moisture analysis, and appearance inspection to guarantee reliability and safety.
Used to manage congestive heart failure (CHF) in dogs, particularly myocardial insufficiency and valvular heart disease.
Improves cardiac contractility, stroke volume, and exercise tolerance.
Reduces clinical symptoms such as lethargy, coughing, and edema.
Applied as a research compound in studies of cardiac physiology and drug development.
Investigated for its mechanistic effects on calcium sensitization and PDE inhibition.
Incorporated into veterinary oral tablets, capsules, and compounded formulations.
Compatible with standard excipients for stable and bioavailable dosage forms.
Standard Packaging:
100 g, 500 g, 1 kg pharmaceutical-grade powder in sealed amber HDPE containers
Custom packaging available upon request
Storage Conditions:
Store in a cool, dry, and dark environment
Keep containers tightly closed
Avoid high temperature, humidity, and direct sunlight
Handle with standard laboratory or pharmaceutical precautions
Avoid inhalation of powder and prolonged skin contact
Use appropriate PPE including gloves, goggles, and lab coat
Consult the Safety Data Sheet (SDS/MSDS) for detailed handling, storage, and emergency instructions
Available upon request:
COA (Certificate of Analysis)
SDS / MSDS
TDS (Technical Data Sheet)
Veterinary pharmaceutical compliance and GMP documentation
✔ High pharmaceutical-grade purity (≥99%)
✔ Suitable for veterinary formulations and research applications
✔ Flexible packaging and bulk supply options
✔ Export-ready documentation and regulatory support
✔ Technical guidance for formulation and dosage development
Q1: What is Pimobendan used for?
It is primarily used to treat congestive heart failure in dogs, improving cardiac output and reducing CHF symptoms.
Q2: Is Pimobendan soluble in water?
It is slightly soluble in water but soluble in organic solvents like methanol and ethanol.
Q3: Can you provide analytical and regulatory documents?
Yes, COA, SDS, TDS, and GMP compliance documents are available.
Q4: What is the typical minimum order quantity (MOQ)?
MOQ depends on packaging and regulatory requirements; please contact us for details.
content is empty!